Avicanna Announces Change in CFO
September 12, 2025 18:00 ET Â | Source: Avicanna Inc. TORONTO, Sept. 12,…
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2025 16:30 ET Â | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass.,…
Sylogist Forms Special Committee and Reiterates Constructive Dialogue and Engagement with all Shareholders
September 13, 2025 00:21 ET Â | Source: Sylogist Ltd. CALGARY, Alberta, Sept.…
Hapbee Strengthens Leadership Team with Key Appointments; Provides Update on Shares-for-Debt Settlement
New leadership roles designed to fast-track Hapbee’s product strategy and accelerate product…
Aja Health And Wellness Inc. Provides Update on Delay in Filing Financial Statements
September 12, 2025 19:34 ET Â | Source: Aja Health and Wellness Inc.…
Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum
September 12, 2025 07:00 ET Â | Source: Cullinan Therapeutics, Inc. CAMBRIDGE, Mass.,…
Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
September 11, 2025 09:00 ET Â | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows…
PrimeEnergy Resources Corporation Recognized Nationally and Locally for Outstanding Performance
Correction to Press Release Issued September 9, 2025, to clarify that At…
Aeluma Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results
Momentum Building with New Contracts, Record Revenue, and Growing Interest Across Multiple…
Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025
September 09, 2025 11:00 ET Â | Source: Chiesi Global Rare Diseases Results…